Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.

2.50
Hdl Handle:
http://hdl.handle.net/11287/595884
Title:
Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.
Authors:
Taylor, James M.; Dunkerley, Sarah; Silver, David A.; Redfern, Andrew; Talbot, Nick J.; Sharpe, Ian T.; Guyver, Paul M.
Abstract:
Achilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT.
Citation:
Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. 2016, 26:23-29 Foot (Edinb)
Publisher:
Elsevier
Journal:
Foot (Edinburgh, Scotland)
Issue Date:
Mar-2016
URI:
http://hdl.handle.net/11287/595884
DOI:
10.1016/j.foot.2015.08.007
PubMed ID:
26802946
Additional Links:
http://www.sciencedirect.com/science/article/pii/S095825921500084X
Type:
Journal Article
Language:
en
ISSN:
1532-2963
Appears in Collections:
General Trauma & Orthopaedics; Radiology Department; 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTaylor, James M.en
dc.contributor.authorDunkerley, Sarahen
dc.contributor.authorSilver, David A.en
dc.contributor.authorRedfern, Andrewen
dc.contributor.authorTalbot, Nick J.en
dc.contributor.authorSharpe, Ian T.en
dc.contributor.authorGuyver, Paul M.en
dc.date.accessioned2016-02-08T15:42:26Zen
dc.date.available2016-02-08T15:42:26Zen
dc.date.issued2016-03en
dc.identifier.citationExtracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. 2016, 26:23-29 Foot (Edinb)en
dc.identifier.issn1532-2963en
dc.identifier.pmid26802946en
dc.identifier.doi10.1016/j.foot.2015.08.007en
dc.identifier.urihttp://hdl.handle.net/11287/595884en
dc.description.abstractAchilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT.en
dc.languageENGen
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttp://www.sciencedirect.com/science/article/pii/S095825921500084Xen
dc.rightsArchived with thanks to Foot (Edinburgh, Scotland)en
dc.subjectWessex Classification Subject Headings::Orthopaedicsen
dc.titleExtracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.en
dc.typeJournal Articleen
dc.identifier.journalFoot (Edinburgh, Scotland)en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.